ArticleHuman gene therapy2014

Tumor necrosis factor-α/CD40 ligand-engineered mesenchymal stem cells greatly enhanced the antitumor immune response and lifespan in mice.

Somayeh Shahrokhi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.